在HPV+ HNSCC中,由M1巨细胞衍生的外体miR-20b通过CCND1促进了放射敏感化
Huan Liu1,2, Siwei Zhang2, Zengchen Liu2
1The First Affiliated Hospital of Harbin Medical University, Harbin Medical University, School of Stomatology, Harbin, Heilongjiang, China.
Frontiers in oncology
|December 15, 2025
概括
富含miR-20b的M1巨衍生外体 (M1外体) 增强了人乳头瘤病毒阳性头支状细胞癌 (HPV+ HNSCC) 的放射治疗灵敏度. 这些M1外体向CCND1,改善DNA损伤的修复和患者的预后.
科学领域:
- 在瘤学瘤学.
- 免疫学 免疫学 免疫学
- 分子生物学分子生物学
背景情况:
- 人类乳头瘤病毒 (HPV) 是头部和部状细胞癌 (HNSCC) 的关键危险因素.
- 与HPV阴性 (HPV-) HNSCC相比,HPV阳性 (HPV+) HNSCC的放射敏感性增加,预后更好.
- M1巨细胞及其衍生的外体 (M1外体) 显示出增强抗瘤活性和放射敏感性的潜力,但它们在HNSCC中的特定作用需要阐明.
研究的目的:
- 研究M1外因子在调节HPV+HNSCC的辐射敏感性的作用和机制.
- 确定M1巨细胞透,miR-20b水平和HNSCC中的放射敏感性之间的相关性.
- 为了确定参与放射敏感化的miR-20b的分子标.
主要方法:
- 免疫组织化学 (IHC) 用于评估HPV状态和巨细胞透到HNSCC组织中.
- 在实验室中培养了M1巨细胞,并通过差异超离心分离隔离了外体.
- 实验室共培系统和miR-20b模仿传染被用于评估M1外体和miR-20b对HPV+HNSCC辐射敏感性的影响.
- 使用TCGA和GEO数据库分析miR-20b表达及其与放射敏感性和预后的相关性.
主要成果:
- 在HPV+HNSCC中,M1巨细胞透率更高,与改善的治疗效果相关.
- 发现M1外体透到HPV+HNSCC中,显著增加它们对辐射的敏感性.
- 与M2巨细胞相比,M1巨细胞显示了较高的miR-20b水平;miR-20b模仿转染增强了HNSCC的放射敏感性.
- 生物信息学和实验分析确定了CCND1作为miR-20b的直接目标,调解其放射敏感作用.
结论:
- M1外体,特别是那些富含miR-20b的外体,在增强HPV+HNSCC的放射敏感性方面发挥着至关重要的作用.
- 该机制涉及通过向CCND1.1调节DNA损伤修复途径.
- 这些发现表明M1外作为一种潜在的治疗策略,以改善HPV+HNSCC患者的放射治疗结果.
相关概念视频
Abnormal Proliferation
5.1K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.1K
The Tumor Microenvironment
7.6K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
7.6K
mTOR Signaling and Cancer Progression
4.6K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
4.6K
Induced Pluripotent Stem Cells
5.3K
Stem cells are undifferentiated cells that divide and produce different cell types. Ordinarily, cells that have differentiated into a specific cell type are terminally differentiated; however, scientists have found a way to reprogram these mature cells so that they dedifferentiate and return to an unspecialized, proliferative state. These cells are pluripotent like embryonic stem cells—able to produce all cell types—and are called induced pluripotent stem cells (iPSCs).
Somatic...
Somatic...
5.3K
MicroRNAs
3.7K
MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
3.7K


